Australians, Leading the Way

Home  /  Post  /  Current Page

The team at The Alfred are running a randomised, double-blinded, trial of balloon angioplasty for CCSVI to reduce the symptoms of Multiple Sclerosis.

Dr. Helen Kavnoudias has been invited to present the trial design and preliminary results at the Leading the Way conference on neurovascular research (at Saskatoon, in the Saskatchewan province of Canada) in the first week of October.

More details on the trial can be read here…